Microsoft Word 02Preface doc

(1)
 
Malaria 
As a research institute for Malaria, KEMRI has implemented epidemiological and 
clinical studies on malaria with the Wellcome Trust in the United Kingdom since 

---

 
85 
 
1989.  KEMRI also has studied the development of a vaccine for malaria in 
cooperation with the Walter Reed Army Institute of Research (WRAIR) and USAID. 
 
(2)
 
HIV/AIDS and STDs 
KEMRI has been appointed a WHO Collaborating Centre on HIV/AIDS.  KEMRI 
also developed and produced an HIV diagnostic kit with JICA, and conducts AIDS 
prevention and research in collaboration with the CDC.     
 
(3)
 
Vector Borne Diseases 
ESACIPAC, which was established in 2001 in collaboration with the MOH and MOE, 
was recognized as a training and research centre for parasitic diseases control through 
the school health system.    ESACIPAC trains not only medical personnel in Kenya, 
but also in neighbouring countries. 
 
As Kenya’s foremost medical research centre under the jurisdiction of the MOH, 
KEMRI conducts comprehensive medical research in various fields, including 
infectious diseases.  KEMRI conducts studies on the epidemiology, immunology, 
molecular biology, virology, bacteriology and prevention and control of 12 diseases, 
including HIV and related infections, opportunistic infections, etc.  In addition, 
KEMRI contributes to the management of the African Forum for Health Science as a 
major research institute in Africa and also contributes to publication of the African 
Journal of Health Science. 
As a training institute, KEMRI also contributes to human resources development in the 
medical sector through the provision of laboratory training for medical students and 
vocational medical school students, and lectures to postgraduate students at the 
Institute of Tropical Medicine and Infectious Diseases.  In addition, training in 
diagnostic technology for medical personnel is carried out as well as the organization 
of medical conferences and meetings in the African region. 
In the area of health services, KEMRI conducts surveillance for various diseases, 
provides the MOH with technical advice, produces HEPCELL II and other diagnostic 
kits, provides testing and diagnostic services for private companies, and disseminates 
the most recent information on each type of disease, both domestically and abroad, as 
a WHO Collaborating Centre.  KEMRI also conducts studies for national 
preparedness in the event of major disease outbreaks based on a request from the 
MOH.    Table 5.7 shows the studies that KEMRI participated in.